$50 Million Clinical Trial Effort Proposed to CIRM Directors
The California stem cell agency has released additional information on its proposed, first-ever funding round for participation in clinical trials.
The plan, expected to be approved on Thursday by directors, would provide $50 million for one or two trials and would be limited to “novel cell therapies from pluripotent stem cells.” Both businesses and non…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.